-
-
-
Several years ago, the PROWESS trial demonstrated a mortality benefit for drotrecogin alfa [activated] (DrotAA; APC) in patients with severe sepsis, and that this benefit was most pronounced in those at high risk of death (ie, APACHE score > 25 or multi-organ dysfunction).
-
The sample for this study comprised 15,846 patients admitted to 51 adult ICUs in 31 hospitals participating in the Centers for Disease Control and Prevention's Nosocomial Infection Surveillance system.
-
The population of the United States is aging and by 2020, there will be 51 million Americans over the age of 65 years.
-
High-Dose Statin Therapy, Value for Older Adults; Simvastatin, Best for
Parkinson's Disease; Polyethylene Glycol for Chronic Constipation; FDA
Actions
-
-
This issue is the second part of a discussion of hand and wrist injuries. The complexity of the anatomy and the variation of injuries provides an explanation of why so many injuries are initially missed.
-
-
Using data from 132 US veterans hospitals collected in the National Surgical Quality Improvement Program, Wu et al performed a retrospective cohort study of patients aged 65 or older who underwent major non-cardiac surgery between 1997 and 2004.
